• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人重组精氨酸酶 I(Co)-聚乙二醇 5000[HuArgI(Co)-PEG5000]诱导的精氨酸耗竭对人急性髓系白血病细胞具有选择性细胞毒性。

Human recombinant arginase I(Co)-PEG5000 [HuArgI(Co)-PEG5000]-induced arginine depletion is selectively cytotoxic to human acute myeloid leukemia cells.

机构信息

Department of Natural Sciences, School of Arts and Sciences, Lebanese American University, Beirut 1102 2801, Lebanon.

出版信息

Leuk Res. 2013 Nov;37(11):1565-71. doi: 10.1016/j.leukres.2013.08.007. Epub 2013 Aug 16.

DOI:10.1016/j.leukres.2013.08.007
PMID:24018014
Abstract

In this study, we target arginine auxotrophy of AML cell lines using human arginase I cobalt-PEG5000. HuArgI(Co)-PEG5000 was cytotoxic to all AML cell lines tested. Mononuclear cells and CD34(+) blasts were not sensitive demonstrating the selectivity of HuArgI(Co)-PEG5000-induced arginine deprivation. Addition of L-citrulline led to the rescue of five cell lines. The four cell lines that were not rescued by L-citrulline did not express argininosuccinate synthetase-1, indicating complete arginine auxotrophy. Inhibition of autophagy increased cell sensitivity to HuArgI(Co)-PEG5000 demonstrating the protective role of autophagy following arginine deprivation. We have shown that AML can be selectively targeted using HuArgI(Co)-PEG5000-induced arginine depletion.

摘要

在这项研究中,我们使用人源精氨酸酶 I 钴-PEG5000 靶向 AML 细胞系的精氨酸营养缺陷型。HuArgI(Co)-PEG5000 对所有测试的 AML 细胞系均具有细胞毒性。单核细胞和 CD34(+) blasts 不敏感,表明 HuArgI(Co)-PEG5000 诱导的精氨酸剥夺具有选择性。添加 L-瓜氨酸可导致 5 种细胞系的恢复。不能被 L-瓜氨酸挽救的 4 种细胞系不表达精氨琥珀酸合成酶-1,表明完全的精氨酸营养缺陷型。自噬的抑制增加了细胞对 HuArgI(Co)-PEG5000 的敏感性,表明自噬在精氨酸剥夺后具有保护作用。我们已经表明,AML 可以使用 HuArgI(Co)-PEG5000 诱导的精氨酸耗竭来选择性靶向。

相似文献

1
Human recombinant arginase I(Co)-PEG5000 [HuArgI(Co)-PEG5000]-induced arginine depletion is selectively cytotoxic to human acute myeloid leukemia cells.人重组精氨酸酶 I(Co)-聚乙二醇 5000[HuArgI(Co)-PEG5000]诱导的精氨酸耗竭对人急性髓系白血病细胞具有选择性细胞毒性。
Leuk Res. 2013 Nov;37(11):1565-71. doi: 10.1016/j.leukres.2013.08.007. Epub 2013 Aug 16.
2
Human recombinant arginase I (Co)-PEG5000 [HuArgI (Co)-PEG5000]-induced arginine depletion is selectively cytotoxic to human glioblastoma cells.人重组精氨酸酶I(Co)-聚乙二醇5000 [HuArgI(Co)-PEG5000]诱导的精氨酸耗竭对人胶质母细胞瘤细胞具有选择性细胞毒性。
J Neurooncol. 2015 Mar;122(1):75-85. doi: 10.1007/s11060-014-1698-5. Epub 2015 Jan 8.
3
Cytotoxicity of human recombinant arginase I (Co)-PEG5000 in the presence of supplemental L-citrulline is dependent on decreased argininosuccinate synthetase expression in human cells.人重组精氨酸酶 I(Co)-PEG5000 在补充 L-瓜氨酸存在下的细胞毒性依赖于人细胞中精氨酸琥珀酸合成酶表达的降低。
Anticancer Drugs. 2012 Jan;23(1):51-64. doi: 10.1097/CAD.0b013e32834ae42b.
4
Cytotoxicity of [HuArgI (co)-PEG5000]-induced arginine deprivation to ovarian Cancer cells is autophagy dependent.[HuArgI (co)-PEG5000]诱导的精氨酸剥夺对卵巢癌细胞的细胞毒性依赖于自噬。
Invest New Drugs. 2020 Feb;38(1):10-19. doi: 10.1007/s10637-019-00756-w. Epub 2019 Mar 18.
5
Activation of autophagy following [HuArgI (Co)-PEG5000]-induced arginine deprivation mediates cell death in colon cancer cells.[HuArgI (Co)-PEG5000]诱导的精氨酸缺乏激活自噬可介导结肠癌细胞死亡。
Hum Cell. 2021 Jan;34(1):152-164. doi: 10.1007/s13577-020-00437-4. Epub 2020 Sep 26.
6
[HuArgI (co)-PEG5000]-induced arginine deprivation leads to autophagy dependent cell death in pancreatic cancer cells.[HuArgI (共)-PEG5000]诱导的精氨酸缺乏导致胰腺癌细胞自噬依赖性细胞死亡。
Invest New Drugs. 2020 Oct;38(5):1236-1246. doi: 10.1007/s10637-019-00883-4. Epub 2019 Dec 10.
7
Human Recombinant Arginase I [HuArgI(Co)-PEG5000]-Induced Arginine Depletion Inhibits Pancreatic Cancer Cell Migration and Invasion Through Autophagy.人重组精氨酸酶I [HuArgI(Co)-PEG5000]诱导的精氨酸耗竭通过自噬抑制胰腺癌细胞的迁移和侵袭。
Pancreas. 2021 Sep 1;50(8):1187-1194. doi: 10.1097/MPA.0000000000001891.
8
Human Recombinant Arginase I [HuArgI (Co)-PEG5000]-Induced Arginine Depletion Inhibits Colorectal Cancer Cell Migration and Invasion.人重组精氨酸酶 I [HuArgI (Co)-PEG5000]诱导的精氨酸耗竭抑制结直肠癌细胞迁移和侵袭。
Int J Mol Sci. 2019 Nov 29;20(23):6018. doi: 10.3390/ijms20236018.
9
Human recombinant arginase I [HuArgI (Co)-PEG5000]-induced arginine depletion inhibits ovarian cancer cell adhesion and migration through autophagy-mediated inhibition of RhoA.人重组精氨酸酶 I [HuArgI (Co)-PEG5000] 诱导的精氨酸耗竭通过自噬介导的 RhoA 抑制抑制卵巢癌细胞黏附和迁移。
J Ovarian Res. 2021 Jan 11;14(1):13. doi: 10.1186/s13048-021-00767-3.
10
Arginine dependence of acute myeloid leukemia blast proliferation: a novel therapeutic target.急性髓系白血病原始细胞增殖对精氨酸的依赖性:一个新的治疗靶点。
Blood. 2015 Apr 9;125(15):2386-96. doi: 10.1182/blood-2014-09-600643. Epub 2015 Feb 20.

引用本文的文献

1
Metabolic Adaptations in Cancer Progression: Optimization Strategies and Therapeutic Targets.癌症进展中的代谢适应:优化策略与治疗靶点
Cancers (Basel). 2025 Jul 15;17(14):2341. doi: 10.3390/cancers17142341.
2
Therapeutic potential of arginine deprivation therapy for gliomas: a systematic review of the existing literature.精氨酸剥夺疗法对神经胶质瘤的治疗潜力:现有文献的系统评价
Front Pharmacol. 2024 Aug 22;15:1446725. doi: 10.3389/fphar.2024.1446725. eCollection 2024.
3
Broad-spectrum anti-cancer activity of fused human arginase variants.
融合型人精氨酸酶变体的广谱抗癌活性。
Invest New Drugs. 2024 Oct;42(5):531-537. doi: 10.1007/s10637-024-01466-8. Epub 2024 Aug 20.
4
Enhancing Leukemia Treatment: The Role of Combined Therapies Based on Amino Acid Starvation.增强白血病治疗效果:基于氨基酸饥饿的联合疗法的作用
Cancers (Basel). 2024 Mar 16;16(6):1171. doi: 10.3390/cancers16061171.
5
Research progress on the role of cationic amino acid transporter (CAT) family members in malignant tumors and immune microenvironment.阳离子氨基酸转运蛋白(CAT)家族成员在恶性肿瘤及其免疫微环境中的作用研究进展。
Amino Acids. 2023 Oct;55(10):1213-1222. doi: 10.1007/s00726-023-03313-1. Epub 2023 Aug 12.
6
Unlocking the Potential of Arginine Deprivation Therapy: Recent Breakthroughs and Promising Future for Cancer Treatment.精氨酸剥夺疗法的潜力解锁:癌症治疗的最新突破和广阔前景。
Int J Mol Sci. 2023 Jun 26;24(13):10668. doi: 10.3390/ijms241310668.
7
Molecular targeted therapy: A new avenue in glioblastoma treatment.分子靶向治疗:胶质母细胞瘤治疗的新途径。
Oncol Lett. 2022 Dec 15;25(2):46. doi: 10.3892/ol.2022.13632. eCollection 2023 Feb.
8
Arginine depriving enzymes: applications as emerging therapeutics in cancer treatment.精氨酸剥夺酶:在癌症治疗中作为新兴治疗方法的应用。
Cancer Chemother Pharmacol. 2021 Oct;88(4):565-594. doi: 10.1007/s00280-021-04335-w. Epub 2021 Jul 26.
9
Amino Acid Metabolic Vulnerabilities in Acute and Chronic Myeloid Leukemias.急性和慢性髓系白血病中的氨基酸代谢脆弱性
Front Oncol. 2021 Jul 1;11:694526. doi: 10.3389/fonc.2021.694526. eCollection 2021.
10
Mitochondrial metabolism as a target for acute myeloid leukemia treatment.线粒体代谢作为急性髓系白血病治疗的靶点
Cancer Metab. 2021 Apr 21;9(1):17. doi: 10.1186/s40170-021-00253-w.